NASDAQ · Financial Statements

Apellis Pharmaceuticals, Inc. (APLS) Financial Statements

$41.03 NASDAQ: APLS Market Cap $5.25B

Apellis Pharmaceuticals, Inc. most recently reported annual revenue of $1.0B, net profit of $22.0M, revenue has compounded at 32.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$67.0M$75.0M$397.0M$781.0M$1.0B
Operating Profit$-536.0M$-595.0M$-517.0M$-165.0M$55.0M
Net Profit$-746.0M$-652.0M$-529.0M$-198.0M$22.0M
EPS$-8.84$-6.15$-4.45$-1.60$0.18
Op Margin-805.7%-788.4%-130.4%-21.1%5.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$882.0M$760.0M$789.0M$885.0M$1.1B
Total Liabilities$683.0M$590.0M$594.0M$657.0M$705.0M
Cash$640.0M$552.0M$351.0M$411.0M$468.0M
Borrowings$210.0M$113.0M$111.0M$470.0M$486.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-563.0M$-514.0M$-595.0M$-88.0M$45.0M
Investing Cash Flow$247.0M$58.0M$-1.0M$-1.0M$-1.0M
Financing Cash Flow$12.0M$-14.0M$10.0M$-235.0M$0
Net Cash Flow$75.0M$-89.0M$-201.0M$60.0M$55.0M
Free Cash Flow$-564.0M$-515.0M$-596.0M$-88.0M$45.0M

Valuation & Return Ratios

MetricValue
PEG Ratio34.47
EV / EBITDA31.97
FCF Yield0.72%
Quick Ratio3.16
Interest Coverage1.25
Return 1Y134.36%
Return 3Y-53.32%
Return 5Y-10.04%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
APLS Overview APLS Dividend Run Stock Screener